NSA 10/29/19 VAC AFM Latent Tuberculosis
Data suggest that current strategies will not be enough to reach the goal of U.S. Tuberculosis (TB) elimination during this century. Most recent recommendations for latent TB suggest starting treatment for TB. Some physicians are not starting or deferring treatment secondary to possible side effects. Also, patient's fear of starting medications is a barrier to giving recommended treatment. The purpose and the need for this CME activity is to learn current guidelines and appropriate treatment for latent Tuberculosis (TB): 1) Perform Tuberculin Skin Testing on All Patients with a History of One or More of the Following: HIV Infection, Injection Drug Use, Homelessness, Incarceration, or Contact with a Person with Pulmonary TB. 2) Administer Treatment to All Persons with Latent TB Infection. Unless Prior Treatment of Latent TB can be documented.
Kaiser Permanente Vacaville Primary Care and Family Medicine physicians.
1. Order appropriate tests for diagnosis of tuberculosis.
2. Discuss the tolerance and side effects of the regimens recommended for latent TB treatment.
3. Follow criteria for discharge/outpatient monitoring for treatment.
Kermit Jones, MD, Internal Medicine, Adult Family Medicine Department, Kaiser Permanente Vacaville
Amanda Thornton, MD, Infectious Disease Dept., Kaiser Permanente Vacaville.
Kaiser Permanente Napa/Solano has determined that the speaker and planner(s) do not have affiliations with any corporate organizations that may constitute a conflict of interest with this presentation. Kaiser Permanente Napa/Solano takes responsibility for the content, quality and scientific integrity of this CME activity. Kaiser Permanente does not endorse any brand-name products.
Kaiser Napa Solano Area is accredited by the California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Kaiser Napa Solano Area designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit(s)™